Skip to main content

Volume 14 - Issue 1 - January, 2002

Case Report
08/01/2008
Celso Acevedo, MD; Richard L. Lindsey, MD; Alan H. Gradman, MD; Denes Korpas, MD
Coronary artery perforation is a rare complication of percutaneous transluminal coronary angioplasty (PTCA) and coronary stenting. This complication most commonly results in a communication between the coronary artery lumen and the...
Coronary artery perforation is a rare complication of percutaneous transluminal coronary angioplasty (PTCA) and coronary stenting. This complication most commonly results in a communication between the coronary artery lumen and the...
Coronary artery perforation is a...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Hugh G. Calkins, MD; Nisha Chandra-Strobos, MD; Thomas A. Hennebry, MB, BCh, BAO, MD
Ebstein’s anomaly of the tricuspid valve is a rare form of congenital heart disease that occurs in 1 in 20,000 live births and has a prevalence of approximately 0.5% among patients with congenital heart disease.1 It is characterized by apical...
Ebstein’s anomaly of the tricuspid valve is a rare form of congenital heart disease that occurs in 1 in 20,000 live births and has a prevalence of approximately 0.5% among patients with congenital heart disease.1 It is characterized by apical...
Ebstein’s anomaly of the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Robert A. Harrington, MD; Can Manh Nguyen, MD; Michael H. Sketch, Jr., MD; Robert H. Peter, MD; David E. Kandzari, MD
Case Description. A 45-year-old male with established coronary artery disease was admitted for 2 weeks of recurrent rest-onset chest pain symptoms. The patient had undergone 2 previous percutaneous coronary interventions at another hospital....
Case Description. A 45-year-old male with established coronary artery disease was admitted for 2 weeks of recurrent rest-onset chest pain symptoms. The patient had undergone 2 previous percutaneous coronary interventions at another hospital....
Case Description. A 45-year-old...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Chi Di Liang, MD; Chiung Jen Wu, MD; Chih Yuan Fang, MD; Sheung Fat Ko, MD
Percutaneous transluminal angioplasty (PTA) has been recognized as a safe, simple and effective alternative to operation for the management of renal artery stenosis (RAS). However, major complications such as complete arterial occlusion and...
Percutaneous transluminal angioplasty (PTA) has been recognized as a safe, simple and effective alternative to operation for the management of renal artery stenosis (RAS). However, major complications such as complete arterial occlusion and...
Percutaneous transluminal...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology ushers in another new and exciting year in the publication of the Journal. During the past year we have witnessed dramatic changes in both our society and our health care system....
Dear Readers, This issue of the Journal of Invasive Cardiology ushers in another new and exciting year in the publication of the Journal. During the past year we have witnessed dramatic changes in both our society and our health care system....
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Rafael Beyar, MD, DSc, MPH; Eugenia Nikolsky, MD, PhD; Luis Gruberg, MD
Since 1977, when Gruentzig introduced balloon angioplasty as a less invasive alternative to coronary artery bypass graft surgery, the results have steadily improved. The proportion of complex patients who undergo this procedure has...
Since 1977, when Gruentzig introduced balloon angioplasty as a less invasive alternative to coronary artery bypass graft surgery, the results have steadily improved. The proportion of complex patients who undergo this procedure has...
Since 1977, when Gruentzig...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Franz R. Eberli, MD; Haresh Mehta, MD; Martin Fleisch, MD; Bernhard Meier, MD, FACC, FESC; Ali R. Garachemani, MD; Stephan Windecker, MD; Tushar Chatterjee, MD
The sizes of introducer sheaths and guiding catheters for percutaneous therapeutic interventions have decreased, which should reduce access-site complications.1–6 However, the use of novel antiplatelet drugs like glycoprotein IIb/IIIa...
The sizes of introducer sheaths and guiding catheters for percutaneous therapeutic interventions have decreased, which should reduce access-site complications.1–6 However, the use of novel antiplatelet drugs like glycoprotein IIb/IIIa...
The sizes of introducer sheaths...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Roxana Mehran, MD; Jeffrey W. Moses, MD; Michael B. Collins, MD; Edward M. Kreps, MD; Milena Adamian, MD; Issam Moussa, MD; Yoshio Kobayashi, MD; Kartik Desai, MD; Gregg W. Stone, MD, FACC, FSCAI; Martin B. Leon, MD; George D. Dangas, MD, PhD
Lower restenosis rates were shown in selected lesions with the first-generation Palmaz-Schatz stent when compared to conventional balloon angioplasty.1 However, because the Palmaz-Schatz stent and its delivery system were rigid, stent...
Lower restenosis rates were shown in selected lesions with the first-generation Palmaz-Schatz stent when compared to conventional balloon angioplasty.1 However, because the Palmaz-Schatz stent and its delivery system were rigid, stent...
Lower restenosis rates were...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Antonio Colombo, MD; Goran Stankovic, MD
The dream of any interventional cardiologist and of most stent companies is to have or find a “Panic stent”. A stent with such unique deliverability may need to compromise with other characteristics such as recoil, radial strength, plaque...
The dream of any interventional cardiologist and of most stent companies is to have or find a “Panic stent”. A stent with such unique deliverability may need to compromise with other characteristics such as recoil, radial strength, plaque...
The dream of any interventional...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
08/01/2008
Todd J. Cohen, MD, FACC, FHRS; Jeffrey Klein
Progression of congestive heart failure (CHF), although somewhat slowed by recent therapeutic developments, continues to be a growing problem among men and women age 50–80 years. It afflicts 2–4 million people in the United States and nearly...
Progression of congestive heart failure (CHF), although somewhat slowed by recent therapeutic developments, continues to be a growing problem among men and women age 50–80 years. It afflicts 2–4 million people in the United States and nearly...
Progression of congestive heart...
08/01/2008
Journal of Invasive Cardiology